Difluprednate 0.05% versus Prednisolone acetate 1% eye drops following phacoemulsification surgery
Phase 3
- Conditions
- Eye Diseases
- Registration Number
- PACTR202207762785564
- Lead Sponsor
- Suez Canal University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- All
- Target Recruitment
- 800
Inclusion Criteria
1.Age more than 50 years
2.Patients diagnosed to have cataract, LOCS III cataract classification: NO = 2 and NC = 2)
Exclusion Criteria
1.Known sensitivity to any of the ingredients in this study medication
2.History of glaucoma or ocular hypertension in the study eye
3.Previous history of steroid-induced increase of intraocular pressure (IOP)
4.Previous ocular surgery
5.history of uveitis
6.Intraoperative complications as posterior capsule rupture
7.Diabetic patients, Pregnancy, Autoimmune patients, and Single eyed patient.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy, safety and tolerability
- Secondary Outcome Measures
Name Time Method Visual acuity